These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 16191225)
1. Epidemiology of cerebrovascular disease related cognitive decline. Qiu C; Fratiglioni L Int Psychogeriatr; 2003; 15 Suppl 1():105-10. PubMed ID: 16191225 [TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population. Qiu C; Winblad B; Fratiglioni L Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218 [TBL] [Abstract][Full Text] [Related]
3. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene]. Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related]
5. Vascular pathologies and cognition in a population-based cohort of elderly people. Fernando MS; Ince PG; J Neurol Sci; 2004 Nov; 226(1-2):13-7. PubMed ID: 15537512 [TBL] [Abstract][Full Text] [Related]
6. Multiple combinations of co-factors produce variants of age-related cognitive decline: a theory. McDonald RJ Can J Exp Psychol; 2002 Sep; 56(3):221-39. PubMed ID: 12271752 [TBL] [Abstract][Full Text] [Related]
7. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [TBL] [Abstract][Full Text] [Related]
11. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
13. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769 [TBL] [Abstract][Full Text] [Related]
14. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Li J; Wang YJ; Zhang M; Xu ZQ; Gao CY; Fang CQ; Yan JC; Zhou HD; Neurology; 2011 Apr; 76(17):1485-91. PubMed ID: 21490316 [TBL] [Abstract][Full Text] [Related]
15. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
16. Vascular cognitive impairment. Gilbert DT West Indian Med J; 2007 Dec; 56(6):479-80. PubMed ID: 18646488 [No Abstract] [Full Text] [Related]
17. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Schönknecht P; Pantel J; Kruse A; Schröder J Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype and lifetime cognitive decline. Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604 [TBL] [Abstract][Full Text] [Related]
19. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
20. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community. Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]